Cargando…

Pharmacodynamics of ATI-2307 in a rabbit model of cryptococcal meningoencephalitis

Cryptococcal meningoencephalitis (CM) is a devastating fungal disease with high morbidity and mortality. The current regimen that is standard-of-care involves a combination of three different drugs administered for up to one year. There is a critical need for new therapies due to both toxicity and i...

Descripción completa

Detalles Bibliográficos
Autores principales:	Giamberardino, Charles D., Tenor, Jennifer L., Toffaletti, Dena L., Palmucci, Julia R., Schell, Wiley, Boua, Jane-Valeriane K., Marius, Choiselle, Stott, Katharine E., Steele, Shelby L., Hope, William, Cilla, Don, Perfect, John R.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	American Society for Microbiology 2023
Materias:	Experimental Therapeutics
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10583688/ https://www.ncbi.nlm.nih.gov/pubmed/37728934 http://dx.doi.org/10.1128/aac.00818-23

Ejemplares similares

605. Efficacy and pharmacokinetics-pharmacodynamics of ATI-2307 in a rabbit model of cryptococcal meningoencephalitis
por: Giamberardino, Charles D, et al.
Publicado: (2022)

Efficacy of APX2039 in a Rabbit Model of Cryptococcal Meningitis
por: Giamberardino, Charles D., et al.
Publicado: (2022)

Pharmacodynamics of Isavuconazole in a Rabbit Model of Cryptococcal Meningoencephalitis
por: Kovanda, Laura L., et al.
Publicado: (2019)

168. Efficacy of the Novel gwt1 Inhibitor APX2039 in a Rabbit Model of cryptococcus Meningitis
por: Shaw, Karen J, et al.
Publicado: (2020)

Efficacy of Oral APX001 in a Murine Model of Cryptococcal Meningitis
por: Schell, Wiley A, et al.
Publicado: (2017)

ATI-2307 Exhibits Equivalent Antifungal Activity in Cryptococcus neoformans Clinical Isolates With High and Low Fluconazole IC(50)
por: Gerlach, Elliot S., et al.
Publicado: (2021)

In Vitro and In Vivo Evaluation of APX001A/APX001 and Other Gwt1 Inhibitors against Cryptococcus
por: Shaw, Karen Joy, et al.
Publicado: (2018)

Gene Expression of Diverse Cryptococcus Isolates during Infection of the Human Central Nervous System
por: Yu, Chen-Hsin, et al.
Publicado: (2021)

Landscape of gene expression variation of natural isolates of Cryptococcus neoformans in response to biologically relevant stresses
por: Yu, Chen-Hsin, et al.
Publicado: (2019)

Gelatinous pseudocysts in cryptococcal meningoencephalitis
por: Ribeiro, Bruno Niemeyer de Freitas, et al.
Publicado: (2020)

An Uncommon Presentation of Cryptococcal Meningoencephalitis
por: Freitas, Isabel, et al.
Publicado: (2022)

Cryptococcal Meningoencephalitis in Phenotypically Normal Patients
por: Cumagun, Pia M., et al.
Publicado: (2023)

Population pharmacokinetics and CSF penetration of flucytosine in adults with HIV-associated cryptococcal meningoencephalitis
por: Stott, Katharine E, et al.
Publicado: (2023)

Concurrent presentation of cryptococcal meningoencephalitis and systemic lupus erythematosus
por: Matsumura, Masami, et al.
Publicado: (2010)

A Case of Recurrent Cryptococcal Meningoencephalitis in an Immunocompetent Female
por: Niknam, Negin, et al.
Publicado: (2014)

A case report of cryptococcal meningoencephalitis presenting as uveitis
por: Abhyankar, Nikita, et al.
Publicado: (2012)

Cryptococcal meningoencephalitis in patients with mantle cell lymphoma on ibrutinib
por: Sun, Kai, et al.
Publicado: (2018)

A Rare Presentation of Cryptococcal Meningoencephalitis in an Immunocompetent Individual
por: Malhotra, Ashwin, et al.
Publicado: (2017)

Population pharmacokinetics of liposomal amphotericin B in adults with HIV-associated cryptococcal meningoencephalitis
por: Stott, Katharine E, et al.
Publicado: (2022)

Structural and In Vivo Studies on Trehalose-6-Phosphate Synthase from Pathogenic Fungi Provide Insights into Its Catalytic Mechanism, Biological Necessity, and Potential for Novel Antifungal Drug Design
por: Miao, Yi, et al.
Publicado: (2017)

Live Imaging of Host-Parasite Interactions in a Zebrafish Infection Model Reveals Cryptococcal Determinants of Virulence and Central Nervous System Invasion
por: Tenor, Jennifer L., et al.
Publicado: (2015)

Importance of Follow-Up Cerebrospinal Fluid Analysis in Cryptococcal Meningoencephalitis
por: Skripuletz, Thomas, et al.
Publicado: (2014)

Cryptococcal meningoencephalitis in HIV/AIDS: when to start antiretroviral therapy?
por: Franco-Paredes, Carlos, et al.
Publicado: (2017)

Magnetic resonance imaging features of gelatinous pseudocysts in cryptococcal meningoencephalitis
por: Zhang, Ping, et al.
Publicado: (2018)

Post-infectious inflammatory response syndrome related to cryptococcal meningoencephalitis
por: Mourão, João Luiz Veloso, et al.
Publicado: (2023)

Genotypic diversity and clinical outcome of cryptococcosis in renal transplant recipients in Brazil
por: Ponzio, Vinicius, et al.
Publicado: (2019)

Cryptococcus neoformans Hyperfilamentous Strain Is Hypervirulent in a Murine Model of Cryptococcal Meningoencephalitis
por: Feretzaki, Marianna, et al.
Publicado: (2014)

Cryptococcal Neuroradiological Lesions Correlate with Severity during Cryptococcal Meningoencephalitis in HIV-Positive Patients in the HAART Era
por: Charlier, Caroline, et al.
Publicado: (2008)

Pleiotropic Effects of Deubiquitinating Enzyme Ubp5 on Growth and Pathogenesis of Cryptococcus neoformans
por: Fang, Wei, et al.
Publicado: (2012)

Genomic Variation across a Clinical Cryptococcus Population Linked to Disease Outcome
por: Sephton-Clark, Poppy, et al.
Publicado: (2022)

Efficacy of Oral Encochleated Amphotericin B in a Mouse Model of Cryptococcal Meningoencephalitis
por: Lu, R., et al.
Publicado: (2019)

Efficacy of an Abbreviated Induction Regimen of Amphotericin B Deoxycholate for Cryptococcal Meningoencephalitis: 3 Days of Therapy Is Equivalent to 14 Days
por: Livermore, Joanne, et al.
Publicado: (2014)

1176. Quality of Life of Previously Healthy Subjects following Cryptococcal Meningoencephalitis
por: Dean, Owen, et al.
Publicado: (2020)

Multiple drugs: Cryptococcal meningoencephalitis and off-label use : case report
Publicado: (2021)

Dexamethasone/methylprednisolone: Off-label use and cryptococcal meningoencephalitis: case report
Publicado: (2022)

Takotsubo Cardiomyopathy Secondary to Cryptococcal Meningoencephalitis in a Patient With Multiple Sclerosis
por: Stephens, Shawna, et al.
Publicado: (2022)

Transcriptional Profiles Elucidate Differential Host Responses to Infection with Cryptococcus neoformans and Cryptococcus gattii
por: Holcomb, Zachary E., et al.
Publicado: (2022)

In Vitro Characterization of the Neurapheresis™ System for the Treatment of Cryptococcal Meningitis
por: Charalambous, Lefko, et al.
Publicado: (2017)

Gender-specific contributing risk factors and outcome of female cryptococcal meningoencephalitis patients
por: Zheng, Hui, et al.
Publicado: (2016)

HIV-Negative Cryptococcal Meningoencephalitis Results in a Persistent Frontal-Subcortical Syndrome
por: Traino, Katherine, et al.
Publicado: (2019)

Cannot write session to /tmp/vufind_sessions/sess_iq5c73i91hkg9m2rspkrpttq93